Tambocor: uses, dosage, safety, and treatment guidance

Tambocor is a class IC sodium-channel-blocking antiarrhythmic used to prevent or treat selected serious supraventricular and ventricular arrhythmias. The active ingredient is flecainide acetate, marketed in various regions under Tambocor and generic flecainide products.

• Indications: paroxysmal atrial fibrillation or flutter, paroxysmal supraventricular tachycardia, and documented life-threatening ventricular arrhythmias in carefully selected patients without inappropriate structural heart disease risk.
• Dosage: individualized once- or twice-daily oral dosing based on arrhythmia, ECG response, age, kidney and liver function, plasma concentration when needed, and interacting medicines.
• Contraindications: cardiogenic shock, certain second- or third-degree atrioventricular or bifascicular blocks without pacing support, and use for non-life-threatening arrhythmia after myocardial infarction or with significant structural heart disease.

What is Tambocor used for?

Tambocor is prescribed for carefully selected patients when its expected clinical benefit outweighs its condition-specific risks.

Paroxysmal atrial fibrillation or flutter, paroxysmal supraventricular tachycardia, and documented life-threatening ventricular arrhythmias in carefully selected patients without inappropriate structural heart disease risk. Diagnosis matters because similar symptoms can arise from conditions that need different treatment. A prescriber considers medical history, current medicines, examination findings, laboratory data, and treatment goals before choosing this drug.

How does Tambocor work?

Flecainide strongly blocks fast sodium channels in cardiac tissue, slowing phase-zero depolarization and conduction through atria, ventricles, and the His-Purkinje system. It widens PR and QRS intervals and can suppress re-entry circuits but can also provoke dangerous arrhythmias.

The pharmacologic effect does not make the medicine suitable for every person with similar symptoms. Patients who plan to buy Tambocor should verify the diagnosis and prescription first, because Tambocor price cannot substitute for clinical selection, monitoring, or authentic supply.

How should Tambocor be taken or used?

Take doses at consistent times with or without food and do not stop or adjust independently. Initiation or dose increases may require hospital or ECG monitoring. An atrioventricular nodal blocker may be prescribed in atrial flutter to prevent rapid one-to-one conduction.

Read the dispensing label every time, use the correct measuring or administration device, and never share prescription medicine. Contact the care team before changing the schedule, crushing a dosage form, switching formulations, or stopping long-term therapy.

Which Tambocor dosage variants are available?

Common marketed variants include 50 mg, 100 mg, and 150 mg tablets, with 10 mg/mL oral liquid available through region-specific or compounded preparations.

Availability and licensed indications differ by country and manufacturer. When comparing where to buy Tambocor 50 mg, 100 mg, and 150 mg tablets, with 10 mg/mL oral liquid available through region-specific or compounded preparations, confirm the precise strength, dosage form, route, and package directions rather than choosing by Tambocor price alone. Products with different release characteristics, concentrations, or routes may not be interchangeable.

What are the most common side effects of Tambocor?

The more frequently reported effects include dizziness, blurred or double vision, headache, nausea, fatigue, tremor, and unsteadiness.

Not every patient experiences these reactions, and their likelihood depends on dose, formulation, duration, health status, and other medicines. Record when symptoms begin and whether they follow a dose. Persistent, worsening, or function-limiting effects should be discussed rather than managed by an unapproved dose change.

Which serious effects require urgent medical care?

New or worsening palpitations, chest pain, fainting, breathlessness, ankle swelling, very slow heartbeat, seizure, or severe weakness requires urgent assessment. Flecainide can cause proarrhythmia, heart block, QRS widening, worsening heart failure, and sudden death.

Emergency warning signs should not be watched at home while waiting for the next routine appointment. Bring the medication package and a current medicine list when seeking urgent help so clinicians can identify the active ingredient, strength, and possible interaction.

Which medicines and substances interact with Tambocor?

Amiodarone can markedly increase flecainide exposure. Quinidine, ritonavir, paroxetine, fluoxetine, bupropion, terbinafine, and other CYP2D6 inhibitors may raise levels. Beta blockers, verapamil, diltiazem, digoxin, and other antiarrhythmics can add conduction or contractility effects.

Give the prescriber and pharmacist a complete list of prescription drugs, nonprescription products, vitamins, supplements, and recreational substances. Interaction risk can arise when another drug is started, stopped, or dose-adjusted, even after a stable period on treatment.

Can Tambocor be used with alcohol?

Alcohol advice depends on the indication, formulation, organ function, and other medicines, so an individualized recommendation is safer than assuming that moderate use is harmless.

Alcohol may worsen dizziness, sedation, dehydration, low blood pressure, impaired glucose control, gastrointestinal irritation, or liver stress where those effects are relevant. Avoid alcohol when the prescriber or product information advises it, and never drive when treatment or alcohol impairs alertness.

Is Tambocor safe during pregnancy or breastfeeding?

Flecainide may be used during pregnancy for selected maternal or fetal arrhythmias under specialist care. It enters breast milk, but breastfeeding decisions can sometimes be supported by infant observation and cardiology guidance.

Tell the prescriber about pregnancy plans, a positive test, breastfeeding, or fertility concerns before treatment whenever possible. Exposure decisions should consider gestational timing, dose, route, untreated disease, safer alternatives, and infant factors.

What monitoring is needed during Tambocor treatment?

Obtain baseline and follow-up ECGs for PR, QRS, QT, rhythm, and heart rate; assess kidney and liver function, electrolytes, heart-failure symptoms, and plasma flecainide concentration in higher-risk situations.

Keep scheduled reviews and report new symptoms between visits. Monitoring is intended to detect loss of effectiveness, organ toxicity, interaction effects, and the need for dose adjustment before a preventable complication becomes severe.

What should be done after a missed dose or overdose?

Take a missed dose only within the prescriber’s advised window and never double. Overdose is a medical emergency that can cause profound conduction delay, ventricular arrhythmia, hypotension, heart failure, seizure, and death.

Do not induce vomiting or improvise a corrective dose. Exact advice depends on the amount, time, formulation, symptoms, age, and medical history, so provide those details promptly to a poison center or emergency clinician.

How should Tambocor be stored and obtained?

Keep tablets or liquid at labeled room temperature protected from moisture and light, and secure them because even modest excess exposure can be dangerous.

Before deciding to buy Tambocor, confirm the authorized dosage form, intact packaging, expiration date, and required monitoring. Tambocor price should remain secondary to prescription accuracy, storage integrity, and licensed dispensing.

People who buy Tambocor should use a licensed pharmacy and contact a qualified clinician if the supplied product differs from the prescription or expected appearance.

Medical information disclaimer

This page provides general education and does not replace diagnosis, prescribing, monitoring, or emergency care. Follow the instructions supplied by the treating clinician and the medicine’s approved local labeling.